Navigation Links
Hall of Fame Shortstop Cal Ripken, Jr. Renews Commitment to Lung Cancer
Date:2/26/2008

Baseball's Ironman Remains Honorary Spokesperson for Lung Cancer Alliance

WASHINGTON, Feb. 26 /PRNewswire-USNewswire/ -- Today, Lung Cancer Alliance (LCA) proudly announced the continuation of its Face in the Fight campaign featuring Hall of Fame Orioles' Shortstop, Cal Ripken, Jr. Ripken continues to headline a nationwide awareness campaign focused on educating the public about lung cancer.

Ripken, known as the Ironman because of his consecutive games streak, lost his father to the disease just weeks before Opening Day in 1999. Ripken joined LCA as a spokesperson in 2007 and renewed his commitment to bring much needed attention to the disease for 2008.

"I am proud to work with Lung Cancer Alliance to help reverse the stigma surrounding the disease," said Ripken. "For too long, lung cancer has been ignored and those diagnosed have been blamed. Lung cancer survivors deserve to be treated with compassion and support regardless of their smoking history."

Lung cancer is the number one cancer killer, killing more Americans each year than breast, prostate and colon cancers--combined. It will take the lives of twice as many women as breast cancer and three times as many men as prostate cancer. Over 60 percent of those diagnosed with lung cancer either quit smoking decades ago or never smoked at all.

"By speaking out about lung cancer, Cal Ripken, Jr. will help bring about the compassion and support so needed for this community," said Laurie Fenton Ambrose, LCA President & CEO. "We graciously thank him for his leadership and commitment to this cause."

The Face in the Fight campaign includes print, broadcast, and radio Public Service Announcements. For more information and to download the PSAs for distribution please visit http://www.lungcanceralliance.org.

Lung Cancer Alliance (http://www.lungcanceralliance.org) is the only national non-profit organization dedicated solely to patient support and advocacy for those living with or at risk for lung cancer. LCA is committed to leading the movement to reverse decades of stigma and neglect by empowering those with or at risk for the disease, elevating awareness and changing health policy.

CONTACT: Kay Cofrancesco of Lung Cancer Alliance, +1-202-744-1541, kay@lungcanceralliance.org


'/>"/>
SOURCE Lung Cancer Alliance
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Wiley-Blackwell renews carbon neutral commitment
2. St. Marys Medical Center Renews RCM & Technology With MED3000
3. Governor Rendell Says 2008-09 Budget Renews Commitment to Vulnerable Pennsylvanians
4. FDA Renews its Contract with Beaumont Technology Usability Center for Leadership of Patient Safety Project
5. ABQAURP Renews Agreement with the National Board of Medical Examiners to Oversee Testing Methodology
6. Heart Association Renews Call for CPR Training
7. FDA Renews Warnings on Pain-Relief Patch
8. Acclamation Systems, Inc. Renews Partnership with Coalition America to Offer Streamlined Repricing and Adjudication Solution
9. Independence Technology, A Johnson & Johnson Company, Renews Its Contract With Creative Technology Services
10. Sanofi-Aventis renews licenses for Genomatix chip analysis pipeline
11. NIH/NCI renews and extends nationwide license for Genomatix software and databases
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/13/2016)... ... 13, 2016 , ... Christie Medical Holdings, Inc. presented the ... VeinViewer® Vision vein finder for the nursing school simulation lab. This ... draw blood, combining technology with traditional technique. , “VeinViewer is a wonderful new ...
(Date:2/12/2016)... ... February 12, 2016 , ... Mystic Buddha Publishing House presents Valentine’s Day ... the biography of Rama - Dr. Frederick Lenz. , According to Publisher ... a Buddhist teacher for teaching and helping others. Valentine’s Day celebrates love in ...
(Date:2/12/2016)... VA (PRWEB) , ... February 12, 2016 , ... ... Feb. 29, 2016 — 1:30 p.m. – 3:00 p.m. EST, http://www.fdanews.com/fixeddosecombination ... in the life cycle of pharmaceutical products, garnering increased attention from all stakeholders ...
(Date:2/12/2016)... (PRWEB) , ... February 12, 2016 , ... ... Lean Leadership Series at Zuckerberg San Francisco General Hospital on April 5-7. The ... new behaviors and create new habits. The workshops cover a broad range of ...
(Date:2/12/2016)... (PRWEB) , ... February 12, 2016 , ... The Jones ... other communities across eastern Texas, is launching a cooperative charity drive with the Tarrant ... , Serving more than 50,000 individuals and families in need, the Tarrant County Food ...
Breaking Medicine News(10 mins):
(Date:2/12/2016)... 12, 2016  Sequent Medical, Inc. announced today that ... evaluate the safety and effectiveness of the WEB™ Aneurysm ... intracranial aneurysms.  Prof Laurent Spelle , MD, Head ... Paris, France and Principal Investigator of the ... France and Germany.  Although patients with ruptured ...
(Date:2/12/2016)... 12, 2016  Eli Lilly and Company (NYSE: LLY ... Alimta® (pemetrexed disodium) vitamin regimen patent would not presently be ... France , Italy and ... product only with dextrose solution.  --> ... Court of Appeal held that Lilly,s patent would be indirectly ...
(Date:2/12/2016)... WILMINGTON, North Carolina , 12 februari ... Laboratories, Inc. (AAI/CML), een toonaangevende leverancier van ... farmaceutische en biotechnologische industrieën, kondigt vandaag een ... en mogelijkheden op haar locatie in ... in vraag heeft geleid tot meerdere recente ...
Breaking Medicine Technology: